Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer.
Saved in:
| Title: | Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer. |
|---|---|
| Authors: | Gale, D.1,2 (AUTHOR), Heider, K.1,2 (AUTHOR), Ruiz-Valdepenas, A.1,2 (AUTHOR), Hackinger, S.3 (AUTHOR), Perry, M.3 (AUTHOR), Marsico, G.3 (AUTHOR), Rundell, V.4 (AUTHOR), Wulff, J.4 (AUTHOR), Sharma, G.3 (AUTHOR), Knock, H.4 (AUTHOR), Castedo, J.2,5 (AUTHOR), Cooper, W.1,2 (AUTHOR), Zhao, H.1,2 (AUTHOR), Smith, C.G.1,2 (AUTHOR), Garg, S.6 (AUTHOR), Anand, S.6 (AUTHOR), Howarth, K.3 (AUTHOR), Gilligan, D.5,7 (AUTHOR), Harden, S.V.1,7 (AUTHOR), Rassl, D.M.2,5 (AUTHOR) |
| Source: | Annals of Oncology. May2022, Vol. 33 Issue 5, p500-510. 11p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
